Key result
Study evaluates the NIH lifespan policy's impact on older adult representation in cardiovascular trials.
Why the study?
To compare the representation of older adults in US interventional cardiovascular disease studies before and after the implementation of the National Institutes of Health Inclusion Across the Lifespan Policy.
Does the National Institutes of Health’s Inclusion Across the Lifespan Policy improve the representation of older adults in interventional cardiovascular disease studies in the US?
Does the National Institutes of Health’s Inclusion Across the Lifespan Policy improve the representation of older adults in interventional cardiovascular disease studies in the US?
This review evaluates whether the NIH Inclusion Across the Lifespan Policy successfully improved the representation of older adults in US cardiovascular trials.
NIH policy impact on older adult representation in cardiovascular trials remains unclear; leaves open need for targeted inclusion strategies.
This review compares representation of older adults in interventional cardiovascular disease studies in the US before and after implementation of the National Institutes of Health’s Inclusion Across the Lifespan Policy.
No takes yet. Share an insight, caveat, or question.
Nanna et al. (2020) studied this question. The NIH Inclusion Across the Lifespan Policy was evaluated to determine its impact on the representation of older adults in US interventional cardiovascular disease trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: